CHINATRIALS 11 Summit Advisory Board

PJ Chen
Vice President, Global Clinical Development/Regulatory Affairs and President
UNITED NEUROSCIENCE TAIWAN
Tong Guo
Vice President, Head of Business Development, Greater China
IQVIA
Yongjiang Hei
Chief Medical Officer, Oncology
ZAI LAB
Ye Hua
Chief Executive Officer
BIONOVA PHARMACEUTICALS
Min Irwin
Chief Executive Officer
REISTONE BIOPHARMA
Frank Jiang
Chief Executive Officer
CSTONE PHARMA
Helen Jiang
Senior Vice President & Chief Medical Officer
QINGFENG MEDICINE
Howe Li
Founder, Chairman & Chief Executive Officer
DELTAMED
Simon Li
Vice President, Chief Medical Officer
CSPC
Jay Mei
Chief Executive Officer & Chairman
ANTENGENE
Bin Peng
Chief Medical Officer
EPIMAB BIOTHERAPEUTICS
Lingshi Tan
Chairman & Chief Executive Officer
DMED
Heidi Wang
Vice President, Head of Global Regulatory Science – China, including Hong Kong
BRISTOL-MYERS SQUIBB
Jingsong Wang
Founder, Chairman & Chief Executive Officer
HARBOUR BIOMED
Jonathan Wang
Senior Managing Director
ORBIMED
Lin Wang
Head of Takeda Development Center; Asia Vice President, Global Medical Science & Development Operation, R&D
TAKEDA
Jason Yang
Chief Medical Officer & Senior Vice President, Clinical Development
CSTONE PHARMACEUTICALS